Home Archive
Archive
2022 Volume 53 Issue 12  Published: 2022-12-10
    Perspectives
  • Manqi LI , Liping WEI , Qiaoyu TAO , Weiwei HE , Yan CHANG
    doi: 10.16522/j.cnki.cjph.2022.12.001

    The efficient delivery of genes to target tissues or target cells by vectors is a critical step in gene therapy. Selecting a suitable, safe, and effective gene delivery vector is an urgent task in gene therapy. Gene therapy delivery vectors can be divided into two categories, viral vectors and nonviral vectors. In this review, the current application status and safety of viral vectors, synthetic nonviral vectors, and biological nonviral vectors are summarized, and the advantages and disadvantages of various delivery vectors are compared. Furthermore, the key points for evaluating the nonclinical safety of gene delivery vectors are summarized to provide references for the selection, application, and safety evaluation of vectors in the field of gene therapy.

  • Review
  • Wangding LU , Yuanyuan GE , Guiliang CHEN , Jian WANG , Jun HE , Huafei LUO , Jingchen ZHANG
    doi: 10.16522/j.cnki.cjph.2022.12.002

    Drug-device combination products are a special class of drug product with relatively high technical barriers. The research of their generic products has been a hot and difficult issue. However, the success rate of the product development is extremely low. Compared with ordinary dosage forms, human factor should be systematically considered in the development of generic drug-device products. Currently, there is no guideline for human factors engineering research in China. This study conducts a comparative analysis of factors based on the latest guidelines from FDA, such as"Comparative Analyses and Related Comparative Use Human Factors Studies for a Drug-Device Combination Product Submitted in an ANDA: Draft Guidance for Industry ", and "Bridging for Drug-Device and Biologic-Device Combination Products: Draft Guidance for Industry ". Several case studies are applied for the illustration of some key considerations on development of generic drug-device combination products to provide a reference for researchers.

  • Review
  • Jiayi YU , Yimeng HAO , Jing MA
    doi: 10.16522/j.cnki.cjph.2022.12.003

    Protein drugs include therapeutic proteins with enzymatic or regulatory activity, targeted protein such as antibody drugs, protein vaccines and protein diagnostics. Protein drugs have been one of the most focused areas in new drug development due to their strong specificity, slight adverse drug reaction and significant therapeutic effect. With the rapid development of protein drugs, higher requirements are put forward for their bioanalysis methods. To support the research of pharmacokinetics and toxicokinetics, more sensitive, accurate and high-throughput bioanalytical methods need to be established. In recent years, LC-MS/MS has emerged as a promising and versatile tool for quantitative analysis of protein drugs, owing to its rapid development. In this study, the application progress of LC-MS/MS to the quantitative analysis of protein drugs is summarized, and the specific experimental process of bottom-up analysis method in detail is introduced, which provides a reference for the study of LC-MS/MS in the determination of protein drugs.

  • Review
  • Xinyang LIU , Shuiping OU , Yun ZHAO , Ming YANG , Sen WANG
    doi: 10.16522/j.cnki.cjph.2022.12.004

    The selection of an effective taste masking technique is the key to improving the taste of drugs, and the research on drug taste masking techniques focuses on the sensitivity and accuracy of bitterness evaluation methods. This paper aims to review the in vivo and in vitro evaluation techniques of drug bitterness, and put an emphasis on advantages, disadvantages, and applicability of these techniques. It is suggested that the scope of determination should be standardized after the evaluation by traditional human taste panel method under the premise of ensuring safety, and then other methods, for example, electronic tongue method, should be used to screen other similar preparations and formulations to provide some references for bitter taste masking research.

  • Review
  • Ying ZHAO , Kexin XU , Hao HU , Huimei WANG , Lianyan WANG
    doi: 10.16522/j.cnki.cjph.2022.12.005

    In the treatment of bladder dysfunctional diseases and bladder tumors, as an emerging therapeutic strategy, nanotechnology provides promising applications for efficient drug delivery in vivo due to its effective size effect and targeting modifications. As an effective administration route for the treatment of bladder diseases, intravesical instillation shows superior efficacy compared with systemic administration. However, periodic urination flushes out the instilled drug, resulting in a reduced duration of action. In addition, the existence of a bladder permeability barrier limits drug penetration into the inflammatory sites and tumor tissues. Therefore, it is crucial to develop a novel nano-drug delivery system. This study reviews researches related to nano-drug delivery systems for the treatment of bladder dysfunctional diseases and bladder tumors, with the aim of providing more ideas and methods for improvement of clinical treatments in the future.

  • Paper
  • Longlong JIN , Yajun ZHANG , Huimin SUN , Yong LU , Xianfu WU
    doi: 10.16522/j.cnki.cjph.2022.12.006

    In order to perform the quality control of mifepristone(1), its 17-stereoisomer, 11β-[4-(N, N-dimethylamino)-1-phenyl]-17α-hydroxy-17β-(1-propinyl)-estra-4,9-dien-3-one(1'), was synthesized. The target product 1' was prepared from easily available 1 via esterification with fuming nitric acid, hydrolysis and inversion of configuration in the presence of AgNO3, with a purity of more than 95%. Meanwhile, its absolute configuration (8S,11R,13S,14S,17R) was determined by electronic circular dichroism.

  • Paper
  • Jingyi ZHANG , Jianwei ZHU , Baohong ZHANG
    doi: 10.16522/j.cnki.cjph.2022.12.007

    The split intein, Nostoc punctiforme(Npu) DnaE, is a site-specific conjugating tool for antibody-drug conjugates(ADC). Its splicing activity is affected by the lysine residues in the C-terminal sequence. This study focused on the splicing activities of different lysine mutants in the C-terminal sequence of Npu DnaE. Five amino acid(arginine, glutamine, glycine, glutamic acid and methionine) mutants were performed to explore the effects of different site-directed mutagenesis on lysine in the C-terminal sequence of the split intein Npu DnaE. The results showed that substitutions of lysine in the C-terminus by arginine, glutamine and methionine maintained splicing activity, and the arginine-substituted C-terminus exhibited the higher splicing efficiency. The ADC, HER2-Lc-SMCC-DM1, was further produced by split intein with arginine-substituted C-terminus, and both the antigen affinity and bioactivity were retained. This research provided technical support for site-specific ADC and protein/peptide synthesis based on the application of the intein.

  • Paper
  • Xiaoming ZHANG , Ying HUANG , Yuling LIANG , Jing LI , Chenggang LIANG
    doi: 10.16522/j.cnki.cjph.2022.12.008

    A cell-based method for recombinant human growth hormone(rhGH) bioactivity evaluation was established to replace in vivo animal experiments. Different concentrations of rhGH were used to stimulate the proliferation of the Nb-2 rat lymphoma cell line(Nb2-11 cell) and luminescent cell viability assay was used to measure the cell proliferation to evaluate the bioactivity of rhGH. The relative potency of rhGH was calculated by the 4-parameter logistic(4PL) regression model. Then, the method parameters were optimized. The specificity, relative accuracy, precision, and linearity of this method were verified. The results showed that this method had good specificity, and the relative bias for relative accuracy range was –6.2% - 0.9%, the correlation coefficient of the linear regression equation was 0.985 0, the geometric coefficient of variation for intermediate precision range was 5.2% - 7.7%, the linear range was 50% - 200%. The biological activities of 15 batches of rhGH products were investigated by the Nb2-11 cell proliferation method and the in vivo animal experiment, respectively. The results showed that these two methods had a good consistency. In this study, the Nb2-11 cell proliferation method for determination of rhGH bioactivity was established and verified, and it could be used as a routine method for rhGH bioactivity evaluation and quality control.

  • Paper
  • Lijia YUAN , Guanru WANG , Junfeng LIU , Jun HE
    doi: 10.16522/j.cnki.cjph.2022.12.009

    Docetaxel(1) is a milestone drug in the field of tumor therapy. However, the marketed 1 injection uses Tween-80 and ethyl alcohol as solubilizers, which is prone to induce allergy and hemolysis, and patients have to take glucocorticoids and antihistaminics prior to administration. According to the feature of 1, two 1-loading formulations were prepared, namely sulfobutylether-β-cyclodextrin(SBE-β-CD) inclusion complexes and long-circulating nanoemulsions. Taking SBE-β-CD as the main body of the complexes, the molar ratio of 1 to SBE-β-CD was set at 1∶70 to prepare SBE-β-CD inclusion complexes of 1, and the formation of these inclusion complexes was verified by X-ray diffraction and differential scanning calorimetry(DSC). The composite emulsifier of 1-loading long-circulating nanoemulsions was screened out by pseudo-ternary phase diagram, and average particle size of the obtained nanoemulsions was 53.3 nm with polydispersity index(PDI) of 0.115. The results of in vitro release test showed that (83.48±3.11)% of 1 released from the SBE-β-CD inclusion complexes within 48 hours in phosphate buffer containing 0.5% Tween-80, while (77.60±4.15)% of 1 released from the long-circulating nanoemulsions within 96 hours. The results of the cytotoxicity test showed that the IC50 values of 1 solution, the inclusion complexes and the long-circulating nanoemulsions against 4T1 murine breast cancer cells were 1.50, 0.45 and 0.30 μg/ml, respectively. The pharmacokinetics in rats showed that compared with the commercial injection, the clearance(Cl) values of the inclusion complexes and the long-circulating nanoemulsions were significantly decreased, while the AUC values were significantly increased, showing a good in vivo sustained-release effect.

  • Paper
  • Junfeng LIU , Junji WANG , Yuan ZHAO , Qin LI , Jun HE
    doi: 10.16522/j.cnki.cjph.2022.12.010

    The nano- and micro-suspensions loaded with meloxicam(1) were prepared by wet milling process and microfluidic homogenization method, respectively. Their formulations and process parameters were optimized and characterized. And the in vitro and in vivo release behaviors of nano- and micro-suspensions were investigated. The in vitro release test was carried out with the dispersion releaser device. The results showed that the release plateau of the nanosuspensions was shortened by 12 h, compared with the microsuspensions. The in vivo test with female SD rats as the models was adopted to investigate the pharmacokinetic behaviors of two kinds of suspensions of 1 after intramuscular injection. The results showed that compared with micro-suspensions, the tmax of nanosuspensions was significantly shortened (1.00 h vs. 16.00 h) and the cmax was increased (5.10 μg/ml vs. 4.20 μg/ml). However, both nanosuspensions and microsuspensions can maintain sustained-release profiles for 144 h. 1-Nanosuspensions with faster systemic absorption could be applied to relieve acute pain, and 1-microsuspensions with stable plasma concentration could be used for treatment of long-term pain.

  • Paper
  • Bo YANG , Qi SHAO , Lan CHEN
    doi: 10.16522/j.cnki.cjph.2022.12.011

    In the study, salbutamol sulfate was taken as a model drug, by replacing test actuators B and C with similar material, connecting valve stem and spray orifice structure to the reference actuator A, several critical quality attributes of metered-dose inhaler, namely aerodynamic particle size distribution(APSD), delivered dose(DD), spray pattern(SP), plume geometry(PG), were determined and compared. At the same time, the fine particle dose(FPD), median mass aerodynamic diameter(MMAD), geometric standard deviation(GSD), DD, ellipse ratio, spray area, plume angle, and plume width were used as the main investigation indexes, the subjective-objective combination weight assignment method was used to set the weight of each index, and the grey relation analysis(GRA) was combined to comprehensively evaluate the multiple indexes. In the comprehensive evaluation process, the grey relation coefficients were higher between actuator A and actuator B for DD, plume angle and plume width; while the coefficients between actuator A and actuator C for FPD, MMAD, ellipse ratio, spray area were higher; and for GSD, the grey relation coefficients were all consistent. Finally, it was concluded that the grey relation degree results of actuator A and actuator B were more consistent through the combination of weight and GRA method, that is, the overall difference was smaller. The method discussed in this research might be a reference for the in vitro multi-index evaluation.

  • Paper
  • Zhen FENG , Shanshan XIAO , Hui CHEN , Jingmin LI , Liming TANG , Meicheng YANG
    doi: 10.16522/j.cnki.cjph.2022.12.012

    The close attention in sterility test of microspheres for injection should be paid to both external sterility and internal sterility, and the difficulty for the method establishment and validation was the internal sterility test. On the basis of investigating the production process, this study selected representative products of microspheres for injection and simulated the dissolution process of the microspheres in the presence of potential microbial contaminants, established two internal sterility inspection methods, one was to dissolve the microspheres in DMSO, and the other was to dissolve the microspheres with a pH 10.0 buffer solution. The sterility test was carried out by direct inoculation method, and the bacterial-tolerant spores were used as the strains of the test microorganisms. The key technical points, such as the solution to be tested, the strains of the test microorganisms and the method suitability test, were discussed. This study could provide a beneficial reference for the development and validation of sterility test for microspheres for injection.

  • Paper
  • Zihui HE , Mo LIU , Junxuan REN , Danwei OUYANG
    doi: 10.16522/j.cnki.cjph.2022.12.013

    A quantitative analysis of multi-components by single marker (QAMS) method was established for the simultaneous determination of six components, namely genistein(2), kaempferol-3-O-rutinoside(3), kaempferol-3-O-β-D-sophoroside(4), sophoricoside(5), sophorobioside(6), kaempferol-3-O-(2″-O-β-D-glucopyranosyl)-β-D-rutinoside(7), in charred Sophora japonica(1). The relative correction factors of 2, 3, 4, 6, and 7 were calculated by UPLC method with 5 as the internal reference. The external standard method and QAMS method were compared to determine the differences in the contents of each component, and chemical pattern recognition was used to evaluate the quality of fifteen batches of 1. The results showed that there was no significant difference between the QAMS method and the external standard method(RSD<2%). The results of hierarchical cluster analysis(HCA) and orthogonal partial least square-discriminant analysis(OPLS-DA) showed that fifteen batches of 1 could be clustered into three classes. The difference was mainly manifested in the contents of 2 and 3, and the contents of ingredients varied greatly between different manufacturers and origins. The established QAMS method was accurate and feasible, which provided a reference for the quality control of 1.

  • Paper
  • Hongye HOU , Songsong WANG , Lei SU , Lingna ZHENG , Yongji GAO
    doi: 10.16522/j.cnki.cjph.2022.12.014

    An HPLC method was established for the determination of R-isomer etiracetam(2) in levetiracetam(1) injection. A CHIRALPAK IG column(4.6 mm×250 mm, 5 μm) was used with amylose tri(3-chloro-5-methylphenyl carbamate) as filler. The analysis was carried out in the isocratic elution mode with 10 mmol/L ammonium acetate∶acetonitrile(70∶30) as the mobile phase. The detection wavelength was 190 nm, the flow rate was 0.7 ml/min, the column temperature was 30 ℃, and the injection volume was 100 μl. The results showed that the separation between peaks of 2 and 1 was good under this chromatographic condition. It was linear for 2 and 1 in the ranges of 0.4 - 8.0 and 0.8 - 8.0 μg/ml, respectively, and the detection limits of 2 and 1 were 10 and 20 ng, respectively. The average recoveries(n=9) of 2 and 1 were 103.84% and 99.10%, with the RSDs of 0.81% and 1.16%, respectively. The RSDs of precision test, stability test and repeatability test were all less than 2.0%, and the durability was good. The established method was simple, accurate, reliable, sensitive and reproducible, which was suitable for the quality control of dextro-rotatory stereoisomer in 1 injection.

  • Paper
  • Rui YANG , Kai XU , Jing ZHANG , Huijuan WANG , Xinyue XIAO
    doi: 10.16522/j.cnki.cjph.2022.12.015

    A pre-column derivatization HPLC method was established for the determination of other amino acids, namely aspartic acid, serine, arginine, glycine, threonine, proline, alanine, valine, methionine, cystine, isoleucine, leucine, tryptophan, isophenylalanine, histidine, lysine hydrochloride and tyrosine, in sodium glutamate. Amino acids were derivatized with 2,4-dinitrofluorobenzene. The results showed that the pre-column derivatization HPLC method had good specificity, and it was linear for above amino acids in the corresponding concentration ranges. The precision and stability of the method were good, and the average recoveries of each amino acid ranged from 90.0% to 110.0%, with the RSDs(n=9) less than 5%. The established method is accurate, reliable and reproducible, which can be used for the determination of other residual amino acids in sodium glutamate.

  • Paper
  • Xiaofeng HAO , Quan HOU , Xia ZENG , Jun YAN , Xiao KE
    doi: 10.16522/j.cnki.cjph.2022.12.016

    A crystallization process of crystal form C of pimavanserin is developed without adding crystal seeds. The industrial crystallization conditions were studied through the investigation of solubility, the selection of crystallization methods and production equipment. The crystallization process and mechanism were explored by combination of in-line and off-line monitoring. X-Ray powder diffraction(PXRD), differential scanning calorimetry(DSC) and thermogravimetric analysis(TGA) were used to investigate and control the crystal quality of the final product. The results showed that the process(suspension crystallization in butanone) was suitable for industrial production with a simple operation procedure, and the obtained crystal form C was stable and controllable.

  • Paper
  • Jie HUANG , Yunsheng YUAN
    doi: 10.16522/j.cnki.cjph.2022.12.017

    As the latest generation of vaccine manufacturing processes, mRNA-based vaccine technology has been successfully applied in vaccine production and clinical applications, such as the coronavirus disease 2019(COVID-19) mRNA vaccine. Compared with the traditional inactivated vaccine or recombinant subunit vaccine, mRNA vaccine has the characteristics of high potency, short development cycles, safety profile, and excellent production universality. Due to the characteristics of mRNA molecules and process particularity, the traditional design concept of biological drugs cannot completely fit its production requirement. How to proceed with the process engineering design of an mRNA vaccine manufacturing facility is worth studying. Because of the high difference in national geographic locations, humanistic characteristics, energy structure, and environmental protection requirements, process engineering design solutions under our local conditions should be explored. Based on approved mRNA vaccine facilities in the United States and Europe Union, this study discusses capacity calculation and analysis based on an assumed production scale(1 billion doses per year) and explores key points of engineering design of the large-scale mRNA vaccine facility process. Production facility layout, clean area classification, personnel and material flow, pressure zones, and air flows are discussed and illustrated to provide a scheme to expedite the domestic establishment of the mRNA vaccine GMP manufacturing facility.

  • Pharmaceutical Management & Information
  • Zhuang QIAN , Yaqun ZHANG , Yanchuan LI , Xiaojun CHEN , Jianjun LYU
    doi: 10.16522/j.cnki.cjph.2022.12.018
  • Pharmaceutical Management & Information
  • Lijia YUAN , Jian WANG
    doi: 10.16522/j.cnki.cjph.2022.12.019
  • Pharmaceutical Management & Information
  • Jingxin XIE , Qing WANG , Mingli LIU , Xianfu WU , Jialin QIAN , Huimin SUN
    doi: 10.16522/j.cnki.cjph.2022.12.020
News